Ahmed Bahi on Lina Merghani’s Critique of Early Withdrawal of Aspirin after PCI
Ahmed Bahi, Critical Care Pharmacist Specialist in Trauma Services at Hamad Medical Corporation, shared on LinkedIn:
”Exciting News in Cardiovascular Research!
I’m thrilled to share that I recently had the opportunity to supervise my pharmD student Lina Merghani in critique of a groundbreaking study published in NEJM focused on the ”early withdrawal of aspirin after percutaneous coronary intervention (PCI) in acute acute coronary syndrome (ACS)”..
In my critique, Dr Lina highlighted benefit vs risk of stopping aspiring after acute ACS.
I want to commend our PharmD student for their hard work and dedication to advancing care for trauma patients.
Your contributions are paving the way for improved patient outcomes.
Let’s continue to push the boundaries of knowledge and improve the lives of our patients.”
Read the full article in NEJM.
Article: Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes
Authors: NEO-MINDSET Trial Investigators
Stay updated with Hemostasis Today.
-
Jan 25, 2026, 14:40Jeannie Devereaux Links PRP and Physical Therapy
-
Jan 25, 2026, 14:25Heghine Khachatryan on Anticoagulation After AFib Ablation: New Evidence from NEJM
-
Jan 25, 2026, 12:42Lale Tokgözoğlu on Cardiovascular Risk Factors in Women
-
Jan 25, 2026, 12:32Dino Mehic on Bleeding Assessment Tools and QoL in BDUC
-
Jan 25, 2026, 12:17Natalie Arnold on 11 Clinical Trials That Will Shape Medicine in 2026
-
Jan 25, 2026, 12:05Wolfgang Miesbach on GTH Certification Program for Haemophilia Centres in German-Speaking Countries
-
Jan 25, 2026, 11:46Luma Mahairi on What High-Functioning Teams Can Learn From The Blood System
-
Jan 24, 2026, 15:54Nicolas Nesseler on How Common and Serious is Post-Op Bleeding After Heart Transplantation
-
Jan 24, 2026, 15:43Roey Tagansky on Tu Youyou and the Rediscovery That Defeated Malaria